List view / Grid view
21 June 2016 | By Victoria White, Digital Content Producer
The idiopathic pulmonary fibrosis (IPF) market will rise substantially from just over $900 million in 2015 to $3.2 billion by 2025, according to GlobalData...
21 June 2016 | By Victoria White, Digital Content Producer
The Phase I study will evaluate the ability of UCART19 to induce molecular remission in paediatric patients with relapsed or refractory CD19 positive B-ALL...
21 June 2016 | By Victoria White, Digital Content Producer
Takeda has dosed the first subject in a Phase IIb field efficacy trial of its norovirus vaccine candidate, TAK-214...
21 June 2016 | By Victoria White, Digital Content Producer
The addition of relebactam is designed to restore activity of imipenem against certain imipenem-resistant strains of Gram-negative bacteria...
21 June 2016 | By Victoria White, Digital Content Producer
A study from University Hospital of Saint-Étienne in France reveals that mobile devices are often also contaminated by viral RNA...
20 June 2016 | By Victoria White, Digital Content Producer
Researchers have discovered that an existing medication, denosumab, may prevent breast cancer in women carrying a faulty BRCA1 gene...
20 June 2016 | By Victoria White, Digital Content Producer
A new approach that uses social media could help OTC brands collect data in a pertinent, low cost manner to support their licensed indications...
20 June 2016 | By Victoria White, Digital Content Producer
Freeline is developing and commercialising gene therapies for bleeding and other life threatening or debilitating disorders...
Enstilar is the first fixed-combination, cutaneous foam spray for the once-daily topical treatment of all extents of plaque psoriasis...
20 June 2016 | By Victoria White, Digital Content Producer
Inovio and GeneOne Life Science have received approval to initiate a Phase I human trial to evaluate Inovio’s Zika DNA vaccine (GLS-5700)...
20 June 2016 | By Victoria White, Digital Content Producer
Verona Pharma has successfully secured funding commitments to raise gross proceeds of £44.7m through a conditional placing with new and existing investors...
20 June 2016 | By Victoria White, Digital Content Producer
A Phase II expansion of the ongoing TATTON trial has been initiated to evaluate savolitinib (AZD6094) in epidermal growth factor receptor (EGFR) mutant non-small cell lung cancer (NSCLC) patients.
20 June 2016 | By Victoria White, Digital Content Producer
Santos will be responsible for Amgen's Operations organisation, including manufacturing, process development, quality, engineering and global supply chain...
17 June 2016 | By Victoria White, Digital Content Producer
Feraccru (ferric maltol) is now available in the UK as a treatment for adults with iron deficiency anaemia in patients with inflammatory bowel disease...
17 June 2016 | By Victoria White, Digital Content Producer
Takeda and M2Gen are to collaborate with ORIEN to speed the development of cancer therapeutics through health informatics...
